Cargando…

Quality of Life and Anxiety in Age Macular Degeneration Patients: A Cross-Sectional Study

(1) Background: Chronic diseases affect patients’ quality of life. Age Macular Degeneration (AMD) is one of the most prevalent chronic ocular diseases. The study aims to measure the anxiety and quality of life related to vision in patients with AMD, as well as the relationship with other visual and...

Descripción completa

Detalles Bibliográficos
Autores principales: Caballe-Fontanet, Daniel, Alvarez-Peregrina, Cristina, Busquet-Duran, Neus, Pedemonte-Sarrias, Eduard, Andreu-Vázquez, Cristina, Sánchez-Tena, Miguel Ángel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776064/
https://www.ncbi.nlm.nih.gov/pubmed/35055640
http://dx.doi.org/10.3390/ijerph19020820
_version_ 1784636740313546752
author Caballe-Fontanet, Daniel
Alvarez-Peregrina, Cristina
Busquet-Duran, Neus
Pedemonte-Sarrias, Eduard
Andreu-Vázquez, Cristina
Sánchez-Tena, Miguel Ángel
author_facet Caballe-Fontanet, Daniel
Alvarez-Peregrina, Cristina
Busquet-Duran, Neus
Pedemonte-Sarrias, Eduard
Andreu-Vázquez, Cristina
Sánchez-Tena, Miguel Ángel
author_sort Caballe-Fontanet, Daniel
collection PubMed
description (1) Background: Chronic diseases affect patients’ quality of life. Age Macular Degeneration (AMD) is one of the most prevalent chronic ocular diseases. The study aims to measure the anxiety and quality of life related to vision in patients with AMD, as well as the relationship with other visual and demographic parameters. (2) Methods: Prospective cross-sectional study in AMD patients. Visual acuity (VA), contrast sensitivity (CS), line difference in the Colenbrander test, and the degree of pathology were measured. Other variables such as gender, age, and time from the diagnosis were also collected. Anxiety was measured with the Spielberger State-Trait Anxiety Inventory (STAI) and quality of life with the National Eye Institute Visual Function Questionnaire (NEI VFQ-25). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist was followed. (3) Results: Patients with higher punctuation in Trait STAI showed lower punctuation in NEI VFQ-25 questionnaire (Spearman coefficient −0.415; p = 0.001). The variables VA, CS, and age were correlated to the quality of life. The relationship between trait anxiety and subscales of NEI VFQ-25 was significant for all subscales (p < 0.05), except for social functioning, peripheral vision, general vision, ocular pain, and driving. (4) Conclusions: AMD patients with higher levels of anxiety show a decrease in their quality of life. The quality of life of AMD patients depends on their VA and CS.
format Online
Article
Text
id pubmed-8776064
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87760642022-01-21 Quality of Life and Anxiety in Age Macular Degeneration Patients: A Cross-Sectional Study Caballe-Fontanet, Daniel Alvarez-Peregrina, Cristina Busquet-Duran, Neus Pedemonte-Sarrias, Eduard Andreu-Vázquez, Cristina Sánchez-Tena, Miguel Ángel Int J Environ Res Public Health Article (1) Background: Chronic diseases affect patients’ quality of life. Age Macular Degeneration (AMD) is one of the most prevalent chronic ocular diseases. The study aims to measure the anxiety and quality of life related to vision in patients with AMD, as well as the relationship with other visual and demographic parameters. (2) Methods: Prospective cross-sectional study in AMD patients. Visual acuity (VA), contrast sensitivity (CS), line difference in the Colenbrander test, and the degree of pathology were measured. Other variables such as gender, age, and time from the diagnosis were also collected. Anxiety was measured with the Spielberger State-Trait Anxiety Inventory (STAI) and quality of life with the National Eye Institute Visual Function Questionnaire (NEI VFQ-25). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist was followed. (3) Results: Patients with higher punctuation in Trait STAI showed lower punctuation in NEI VFQ-25 questionnaire (Spearman coefficient −0.415; p = 0.001). The variables VA, CS, and age were correlated to the quality of life. The relationship between trait anxiety and subscales of NEI VFQ-25 was significant for all subscales (p < 0.05), except for social functioning, peripheral vision, general vision, ocular pain, and driving. (4) Conclusions: AMD patients with higher levels of anxiety show a decrease in their quality of life. The quality of life of AMD patients depends on their VA and CS. MDPI 2022-01-12 /pmc/articles/PMC8776064/ /pubmed/35055640 http://dx.doi.org/10.3390/ijerph19020820 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Caballe-Fontanet, Daniel
Alvarez-Peregrina, Cristina
Busquet-Duran, Neus
Pedemonte-Sarrias, Eduard
Andreu-Vázquez, Cristina
Sánchez-Tena, Miguel Ángel
Quality of Life and Anxiety in Age Macular Degeneration Patients: A Cross-Sectional Study
title Quality of Life and Anxiety in Age Macular Degeneration Patients: A Cross-Sectional Study
title_full Quality of Life and Anxiety in Age Macular Degeneration Patients: A Cross-Sectional Study
title_fullStr Quality of Life and Anxiety in Age Macular Degeneration Patients: A Cross-Sectional Study
title_full_unstemmed Quality of Life and Anxiety in Age Macular Degeneration Patients: A Cross-Sectional Study
title_short Quality of Life and Anxiety in Age Macular Degeneration Patients: A Cross-Sectional Study
title_sort quality of life and anxiety in age macular degeneration patients: a cross-sectional study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776064/
https://www.ncbi.nlm.nih.gov/pubmed/35055640
http://dx.doi.org/10.3390/ijerph19020820
work_keys_str_mv AT caballefontanetdaniel qualityoflifeandanxietyinagemaculardegenerationpatientsacrosssectionalstudy
AT alvarezperegrinacristina qualityoflifeandanxietyinagemaculardegenerationpatientsacrosssectionalstudy
AT busquetduranneus qualityoflifeandanxietyinagemaculardegenerationpatientsacrosssectionalstudy
AT pedemontesarriaseduard qualityoflifeandanxietyinagemaculardegenerationpatientsacrosssectionalstudy
AT andreuvazquezcristina qualityoflifeandanxietyinagemaculardegenerationpatientsacrosssectionalstudy
AT sancheztenamiguelangel qualityoflifeandanxietyinagemaculardegenerationpatientsacrosssectionalstudy